查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404818

基于肿瘤的分子诊断市场规模、份额和趋势分析报告：按类型、产品、技术、地区和细分市场预测，2023-2030

Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 139 Pages | 商品交期: 2-10个工作天内

价格

基于肿瘤学的分子诊断市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球肿瘤分子诊断市场规模预计将达到60亿美元，2023年至2030年复合年增长率为12.1%。

老年人口的增加、全球癌症盛行率的增加、久坐生活方式的普及上升、意识提升和病患教育是预测期内基于肿瘤学的分子诊断市场成长的驱动力。

由于久坐的生活方式和免疫力下降而导致癌症患者数量的增加，预计将提高该行业的成长率。此外，在巴西、墨西哥、南非和印度等新兴国家，癌症发病率和死亡率的巨大差异促进了分子诊断的使用，透过早期检测和检验来提高存活率。

基于肿瘤学的分子诊断市场报告亮点

  • 由于高检测量和丰富的商业化产品组合，乳癌将在 2022 年占据整个市场的收益占有率。
  • 由于技术先进的微阵列和检测方法（例如 miRNA 微阵列）的出现，预计大肠在预测期内将呈现良好的成长趋势。
  • 以产品划分，试剂业务在 2022 年总收益中所占份额最高，接近 58.0%。研究人员不断努力检测用于药物开发的新型疾病相关生物标记物，估计是该领域成长的主要驱动力。
  • 聚合酶炼式反应 (PCR) 技术领域的收益占有率最高，2022 年为 31%。这是由于实验室的广泛使用以及对增强诊断的需求不断增长。
  • 预计定序产业在预测期内将出现 14.3% 的大幅成长。提供高通量分析和基因组资料定序的次世代定序技术的进步是显着成长的关键驱动力之一。
  • 北美地区主导市场，2022 年销售份额超过 40%。该地区市场的强劲成长归因于其完善的医疗基础设施、不断增长的健康意识人口基数以及高昂的医疗成本。
  • 由于目标人口庞大、癌症检测意识层级不断提高以及该地区政府措施的增加，亚太地区预计将以 15.8% 的复合年增长率增长最快，并在预测期内实现最大的市场占有率。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章基于肿瘤学的分子诊断市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 基于肿瘤学的分子诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章基于肿瘤的分子诊断市场：类型估计和趋势分析

  • 基于肿瘤学的分子诊断市场：重点
  • 基于肿瘤学的分子诊断市场：2022 年和 2030 年类型变动和市场占有率分析
  • 乳癌
    • 2018-2030 年乳癌市场估计与预测
  • 摄护腺癌
    • 2018-2030 年前列腺癌市场估计与预测
  • 大肠直肠癌
    • 2018-2030 年大肠癌市场估计与预测
  • 子宫颈癌
    • 2018-2030 年子宫颈癌市场估计与预测
  • 肝癌
    • 2018-2030 年肝癌市场估计与预测
  • 肺癌
    • 2018-2030 年肺癌市场估计与预测
  • 血癌
    • 2018-2030 年血癌市场估计与预测
  • 肾癌
    • 2018-2030 年肾癌市场估计与预测
  • 其他癌症
    • 2018-2030 年其他癌症市场估计与预测

第五章基于肿瘤的分子诊断市场：产品评估与趋势分析

  • 基于肿瘤学的分子诊断市场：重点
  • 基于肿瘤学的分子诊断市场：2022 年和 2030 年产品趋势和市场占有率分析
  • 装置
    • 2018-2030 年设备市场估计与预测
  • 试剂
    • 2018-2030 年试剂市场估计与预测
  • 其他的
    • 2018-2030 年其他产品的市场估计与预测

第六章基于肿瘤的分子诊断市场：技术评估与趋势分析

  • 基于肿瘤学的分子诊断市场：重点
  • 基于肿瘤学的分子诊断市场：2022 年和 2030 年技术趋势和市场占有率分析
  • PCR
    • 2018-2030 年 PCR 市场估计与预测
  • 原位杂交
    • 原位杂交市场估计与预测，2018-2030
  • INAAT
    • 2018-2030 年 INAAT 市场估计与预测
  • 晶片微阵列
    • 2018-2030 年晶片/微阵列市场估计与预测
  • 质谱
    • 2018-2030 年质谱市场估计与预测
  • 顺序
    • 2018-2030年序列市场估算与预测
  • TMA
    • 2018-2030 年 TMA 市场估计与预测
  • 其他的
    • 2018-2030 年其他市场估计与预测

第七章基于肿瘤的分子诊断市场：区域估计和趋势分析

  • 区域展望
  • 基于肿瘤学的分子诊断市场（按地区）：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • Abbott
    • Bayer AG
    • BD
    • Cepheid
    • Agilent Technologies, Inc.
    • Danaher
    • Hologic, Inc.
    • Qiagen
    • F. Hoffmann-La Roche Ltd.
    • Siemens
    • Sysmex
Product Code: 978-1-68038-699-8

Oncology Based Molecular Diagnostics Market Growth & Trends:

The global oncology based molecular diagnostics market size is expected to reach USD 6.00 billion by 2030, registering a CAGR of 12.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising geriatric population base, increasing global prevalence of cancer, rise in sedentary lifestyle adoption levels, and rising awareness & patient education are the driving forces for the oncology based molecular diagnostics market growth over the forecast period.

Growing prevalence of cancer patients owing to adoption of sedentary lifestyles and decrease in immunity levels are estimated to increase industrial growth rate. Furthermore, large variations in both cancer incidence and mortality rates in different sub-regions of developing countries such as Brazil, Mexico, South Africa, and India are also anticipated to enhance the usage of molecular diagnostics to increase survival rates by early detection and validation.

Oncology Based Molecular Diagnostics Market Report Highlights:

  • Breast cancer dominated the overall market in 2022 in terms of revenue share due to large test volumes and an extensive portfolio of commercialized products.
  • Colorectal cancer is estimated to witness lucrative growth over the forecast period owing to the availability of technologically advanced microarrays & assays such as miRNA microarrays.
  • On the basis of product, the reagents segment held the highest share of almost 58.0% of the overall revenue in 2022. Growing initiatives by researchers in this field for detection of disease related novel biomarkers for drug development purpose are estimated to be the key factors attributing to this segment's growth
  • The polymerase chain reaction (PCR) technology segment held the highest revenue share of 31% in 2022. This can be attributed to its growing utilization in research labs and the increased need for enhanced diagnostics.
  • The sequencing segment is anticipated to witness a significant growth rate of 14.3% during the forecast period. Development of next generation sequencing techniques providing high throughput analysis and sequencing of genomic data is one of the key drivers for significant growth.
  • North America dominated the market with a revenue share of over 40% in 2022 The strong market growth in this region can be attributed to a well-established healthcare infrastructure, the constantly rising health-conscious population base, and high healthcare expenditure.
  • Asia Pacific region is expected to advance at the fastest CAGR of 15.8% during the projection period owing to the presence of a large number of target population, rising awareness levels for cancer detection, and increasing government initiatives in this region enabling the achievement of the largest market share

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Product
    • 1.1.3. Technology
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Product outlook
    • 2.2.3. Technology outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Oncology Based Molecular Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Oncology Based Molecular Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Oncology Based Molecular Diagnostics Market: Type Estimates & Trend Analysis

  • 4.1. Oncology Based Molecular Diagnostics Market: Key Takeaways
  • 4.2. Oncology Based Molecular Diagnostics Market: Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Breast Cancer
    • 4.3.1. Breast cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Prostate Cancer
    • 4.4.1. Prostate cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Colorectal Cancer
    • 4.5.1. Colorectal cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Cervical Cancer
    • 4.6.1. Cervical cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Liver Cancer
    • 4.7.1. Liver cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Lung Cancer
    • 4.8.1. Lung cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Blood Cancer
    • 4.9.1. Blood cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Kidney Cancer
    • 4.10.1. Kidney cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. Other Cancer
    • 4.11.1. Others cancer market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Oncology Based Molecular Diagnostics Market: Product Estimates & Trend Analysis

  • 5.1. Oncology Based Molecular Diagnostics Market: Key Takeaways
  • 5.2. Oncology Based Molecular Diagnostics Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Instruments
    • 5.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Reagents
    • 5.4.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Other products market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Oncology Based Molecular Diagnostics Market: Technology Estimates & Trend Analysis

  • 6.1. Oncology Based Molecular Diagnostics Market: Key Takeaways
  • 6.2. Oncology Based Molecular Diagnostics Market: Technology Movement & Market Share Analysis, 2022 & 2030
  • 6.3. PCR
    • 6.3.1. PCR market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. In situ hybridization
    • 6.4.1. In situ hybridization market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. INAAT
    • 6.5.1. INAAT market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Chips and microarrays
    • 6.6.1. Chips and microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Mass spectrometry
    • 6.7.1. Mass spectrometry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Sequencing
    • 6.8.1. Sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.9. TMA
    • 6.9.1. TMA market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.10. Others
    • 6.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Oncology Based Molecular Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Oncology Based Molecular Diagnostics Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. U.K.
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Abbott
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Bayer AG
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. BD
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Cepheid
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Agilent Technologies, Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Danaher
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Hologic, Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Qiagen
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. F. Hoffmann-La Roche Ltd.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Siemens
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Sysmex
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 3 North America Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 North America Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 5 North America Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 U.S. Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 8 U.S. Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 9 Canada Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 Canada Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 Canada Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 Europe Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 13 Europe Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 Europe Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15 Europe Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 16 Germany Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 17 Germany Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Germany Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 UK Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 20 UK Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 21 UK Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 22 France Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 France Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 France Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 Italy Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 26 Italy Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Italy Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 Spain Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 29 Spain Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 30 Spain Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 Sweden Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 32 Sweden Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 33 Sweden Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 34 Norway Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Norway Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 Norway Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 Denmark Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 38 Denmark Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Denmark Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 44 China Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 45 China Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 46 China Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Japan Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 48 Japan Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 Japan Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 50 India Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 India Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 India Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Thailand Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 54 Thailand Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Thailand Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 56 South Korea Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 57 South Korea Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 58 South Korea Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 59 Australia Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 60 Australia Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Australia Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Latin America Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 63 Latin America Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Latin America Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 65 Latin America Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 66 Brazil Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 67 Brazil Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 Brazil Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Mexico Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 70 Mexico Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 71 Mexico Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 72 Argentina Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 74 Argentina Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa Oncology Based Molecular Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 79 South Africa Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 South Africa Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 81 South Africa Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 UAE Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 86 UAE Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 87 UAE Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Oncology Based Molecular Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Oncology Based Molecular Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Oncology Based Molecular Diagnostics Market, by Technology, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Oncology based molecular diagnostics market: market outlook
  • Fig. 9 Oncology based molecular diagnostics market competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Oncology based molecular diagnostics market driver impact
  • Fig. 15 Oncology based molecular diagnostics market restraint impact
  • Fig. 16 Oncology based molecular diagnostics market strategic initiatives analysis
  • Fig. 17 Oncology based molecular diagnostics market: type movement analysis
  • Fig. 18 Oncology based molecular diagnostics market: type outlook and key takeaways
  • Fig. 19 Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Colorectal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Cervical cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Liver cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Blood cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Kidney cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Other cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Oncology based molecular diagnostics market: product movement analysis
  • Fig. 29 Oncology based molecular diagnostics market: product outlook and key takeaways
  • Fig. 30 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Oncology based molecular diagnostics market: technology movement analysis
  • Fig. 34 Oncology based molecular diagnostics market: technology outlook and key takeaways
  • Fig. 35 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 In Situ Hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 INAAT market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Chips and microarrays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Mass spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 TMA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Global oncology based molecular diagnostics market: regional movement analysis
  • Fig. 44 Global oncology based molecular diagnostics market: regional outlook and key takeaways
  • Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)